Silence Therapeutics (SLN) Shares Outstanding (2020 - 2026)

Silence Therapeutics' Shares Outstanding history runs 7 years deep, the most recent figure standing at $141.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding changed 0.01% year-over-year to $141.7 million; the TTM figure through Mar 2026 stood at $141.7 million (changed 0.01% YoY), while the FY2025 annual figure was $141.7 million, up 200.06% from the prior year.
• Shares Outstanding came in at $141.7 million for Q1 2026 at Silence Therapeutics, roughly flat from $141.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $184.0 million in Q3 2024 to a low of $42.2 million in Q4 2022.
• A 5-year average of $126.3 million and a median of $141.7 million in 2025 frame the typical range for Shares Outstanding.
• On a YoY basis, Shares Outstanding climbed as much as 200.06% in 2025 and fell as far as 74.33% in 2025.
• Silence Therapeutics' Shares Outstanding stood at $126.5 million in 2022, then rose by 16.65% to $147.5 million in 2023, then slumped by 67.98% to $47.2 million in 2024, then soared by 200.06% to $141.7 million in 2025, then grew by 0.0% to $141.7 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $141.7 million, $141.7 million, and $47.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison